Illumina to Announce Fourth Quarter and Full Year 2024 Financial Results on Thursday, February 6, 2025
Illumina to Announce Fourth Quarter and Full Year 2024 Financial Results on Thursday, February 6, 2025
The conference call will begin at SAN DIEGO, Jan. 9, 2025 /PRNewswire/ -- Illumina, Inc. (NASDAQ:ILMN) announced today that it will issue results for the fourth quarter and full year 2024 following the close of market on Thursday, February 6, 2025.
聖地亞哥，2025年1月9日 / PRNewswire / -- Illumina，Inc.（納斯達克：ILMN）今天宣佈，將在2025年2月6日（星期四）市場收盤後發佈2024年第四季度和全年業績。
On the same day, at 1:30 pm Pacific Time (4:30 pm Eastern Time) Jacob Thaysen, PhD, Chief Executive Officer, and Ankur Dhingra, Chief Financial Officer, will host a conference call with analysts, investors, and other interested parties to discuss financial and operating results.
在同一天，太平洋時間下午1:30（東部時間下午4:30），首席執行官Jacob Thaysen博士和財務長Ankur Dhingra將主持與分析師、投資者及其他相關方的電話會議，討論財務和運營結果。
Conference Call Details
電話會議詳情
The conference call will begin at 1:30 pm Pacific Time (4:30 pm Eastern Time) on Thursday, February 6, 2025. Interested parties may access the live webcast via the Investor Info section of Illumina's website or directly through the following link - . To ensure timely connection, please join at least ten minutes before the scheduled start of the call.
電話會議將於2025年2月6日（星期四）太平洋時間下午1:30（東部時間下午4:30）開始。相關方可以通過Illumina網站的投資者信息部分或直接通過以下鏈接訪問現場網絡廣播。爲確保及時連接，請至少在電話會議開始前十分鐘加入。
A replay of the conference call will be posted on Illumina's website after the event and will be available for at least 30 days following.
電話會議的重播將在活動後發佈在Illumina的網站上，並將在至少30天內可用。
About Illumina
關於Illumina
Illumina is improving human health by unlocking the power of the genome. Our focus on innovation has established us as a global leader in DNA sequencing and array-based technologies, serving customers in the research, clinical, and applied markets. Our products are used for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments. To learn more, visit and connect with us on X (Twitter), Facebook, LinkedIn, Instagram, TikTok, and YouTube
Illumina正在通過解鎖基因組的力量來改善人類健康。我們對創新的關注使我們成爲DNA測序和基於陣列技術的全球領導者，爲研究、臨牀和應用市場的客戶提供服務。我們的產品通常用於生命科學、腫瘤學、生殖健康、農業及其他新興領域的應用。要了解更多信息，請訪問，並在X（Twitter）、Facebook、LinkedIn、Instagram、TikTok和YouTube與我們聯繫。
Investors:
Salli Schwartz
+1.858.291.6421
[email protected]
投資者：
薩莉·施瓦茨
+1.858.291.6421
[email protected]
Media:
Bonny Fowler
+1.740.641.5579
[email protected]
媒體：
邦尼·福勒
+1.740.641.5579
[email protected]
SOURCE Illumina, Inc.
來源 Illumina, Inc.
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
想讓貴公司的資訊在PRNEWSWIRE.COM上特色展示嗎？
譯文內容由第三人軟體翻譯。
